LQFM-215 | Interleukin Related interleukin-related.com

Product Name :
LQFM-215

Search keywords :
LQFM215

drugId :
null

Target Vo:
Sodium-dependent proline transporter

Target Vo Short Name :
SLC6A7

Moa_Name:
Sodium-dependent proline transporter inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Universidade Federal De Goiás

Active Company_Name :
Universidade Federal De Goiás

Active Indication_Name:
Schizophrenia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Figitumumab IGF-1R
Isatuximab web
Retinoic Acid Receptor alpha Antibody: Retinoic Acid Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoic Acid Receptor alpha. It can be used for WB,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts